An oral fern extract used to complement sunscreen from the inside out. Its most reliable effect is a modest rise in how much sun the skin tolerates before reddening, plus less molecular sun damage and some help with facial pigment patches. Safety is favorable. The protection is small and cannot replace sunscreen. (Full Review)

Protocol

Standard Dose

240 mg

Once or twice daily; 480 mg/day for intense sun exposure

Timing

Before sun exposure

Shortly before anticipated exposure; effect is transient

Split Dosing

Morning + midday

For prolonged all-day exposure; single morning dose for general use

Time to effect

Sun Protection

2-3 hours

Photoprotective effect after each dose; short-lived

Pigmentation & Skin Quality

8-12 weeks

Visible changes with consistent use

Benefits

High: Reduced UV-induced sunburn response and skin damage

Medium: Reduced UV-induced DNA damage and photoaging biomarkers; adjunctive benefit in melasma; prevention of polymorphous light eruption

Low: Preservation of dermal collagen and elastic fibers; reduction of post-procedure redness and pigmentation

Speculative: Long-term reduction in visible photoaging; systemic antioxidant support for overall skin longevity

Contraindications

Pregnancy or breastfeeding

Known fern or plant allergy

Young children

Key Interactions

Photosensitizing drugs (doxycycline, hydrochlorothiazide, amiodarone)

Oral photoprotective supplements (nicotinamide, carotenoids, marine-derived antioxidants)

Risk & Side Effects

Medium: Gastrointestinal discomfort; overreliance reducing sun-protective behavior

Low: Pruritus and minor skin reactions

Speculative: Hypersensitivity or allergic reaction; uncertain safety in pregnancy and lactation; theoretical immune modulation with long-term use

Monitoring

Marker	Target	Why
25-Hydroxyvitamin D	40-60 ng/mL	Consistent photoprotection can reduce skin vitamin D synthesis
High-sensitivity C-reactive protein (hs-CRP)	< 1.0 mg/L	Tracks systemic inflammatory load the extract may influence
Melasma Area and Severity Index (MASI)	Lower is better	Objectively follows melasma response over time

Cadence: Reassess at 8-12 weeks, then every 6-12 months during continued use

Qualitative Assessment

Fewer or milder sun-triggered rashes or flares
Reduced tendency to burn or redden with sun exposure
Visible lightening or stabilization of pigmentation patches
Subjective skin comfort, tone evenness, and texture

Polypodium leucotomos for Skin Rejuvenation

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment